Intra-cranial malignant peripheral nerve sheath tumor of olfactory nerve: A case report and review of literature by Aggarwal, Varun et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Romanian Neurosurgery  |  Volume XXXII  |  Number 3 |  2018  |  July - September 
 
 
 
 
 
DOI: 10.2478/romneu-2018-0059 
Article 
 
 Intra-cranial malignant peripheral nerve sheath 
tumor of olfactory nerve: a case report and 
review of literature 
 
 
Varun Aggarwal, Amit Narang, Chandni Maheshwari, Divya Kavita 
INDIA 
 
 
 
 
 
 
 
 
 
 
 
 
Romanian Neurosurgery (2018) XXXII 3: 469 - 472 | 469 
 
 
 
 
 
 
 
DOI: 10.2478/romneu-2018-0059   
Intra-cranial malignant peripheral nerve sheath tumor of 
olfactory nerve: a case report and review of literature 
Varun  Aggarwal, Amit Narang, Chandni Maheshwari, Divya Kavita 
Baba Farid University of Health Sciences. Faridkot. Punjab, INDIA 
 
Abstract: Malignant Peripheral Nerve Sheath Tumors (MPNSTs) are one of the very rare 
high grade malignancies usually affecting extremities or trunk. Incidence is 1/Lac. Intra-
cranial MPNSTs are even rarer, schwannomatous and commonly affecting cranial nerves 
VIII &VII). Intra-cranial MPNSTs are usually sporadic, arising de novo. The second 
most common mode of origin is from malignant transformation from pre-existing 
schwannomas or neurofibroma. We present an extremely rare and probably the first case 
of intra-cranial malignant peripheral nerve sheath tumor of the olfactory nerve in a non 
neurofibrosis patient with no prior history of irradiation. 
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Introduction 
Malignant peripheral nerve sheath tumor 
MPNSTs usually arise from peripheral nerves 
or shows differentiation towards nerve sheath 
cells. [9] MPNST of cranial nerves is very rare. 
The incidence of MPNST in the general 
population is 0.001% [8]. They constitute 5-10 
% of all soft tissue sarcomas and 50-70% are 
associated with Neurofibromatosis type 1 (NF-
1).[3,10] MPNSTs involving the Head and 
neck region comprise only 04-08 % of all 
MPNSTs.[1] MPNST arising from olfactory 
nerve  without any features of 
neurofibromatosis type 1 or type 2 as has been 
noted in our case. In the background of 
extensive literature search and with the best of 
our knowledge, probably this is the first case 
report of MPNST arising from olfactory nerve. 
Case history 
A 45 years old male presented to us with 
history of headache and bilateral loss of smell 
since six months and altered sensorium since 
seven days. On examination he had frontal 
lobe signs and features of foster Kennedy 
syndrome. 
His Pre-operative MRI, T1 and T2 
weighted images had 8x7x5 cm heterogeneous 
lesion originating from the anterior cranial 
fossa. On CEMRI (Figure 1) lesion was 
heterogeneously enhancing. His metastatic 
work up was negative. Patient was planned for 
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surgery with diagnosis of atypical olfactory 
groove meningioma.  
He underwent bifrontal craniotomy and 
gross total excision of the tumor (Figure 2). 
Histopathology was suggestive of 
malignant peripheral nerve sheath tumor of 
the olfactory nerve. Post operatively patient 
was discharged on 7th post op day with no fresh 
deficit. Patient underwent post op 
radiotherapy and is recurrence free since last 
six months.  
Discussion 
MPNSTs of the cranial nerves are rare 
tumors, and the literature is limited to isolated 
case reports and small case series. [9] In 
general population, the incidence of MPNST is 
1/Lac population per year. [1] MPNSTs 
generally occur typically between ages 20-50 
years whereas 10-20% of cases have been 
reported in the first 2 decades.[4,8]  The 
common sites of origin include the extremities 
and trunk, usually sciatic nerve, brachial 
plexus and the sacral plexus MPNSTs of head 
and neck region comprise 04-08% of all 
MPNSTs and especially the cranial nerves 
involvement is extremely rare with only few 
cases or short case series found in the 
literature.[9] Most common intracranial 
MPNSTs are found in VIII & V cranial 
nerves.[7]   In retrospective analysis of intra 
cranial MPNSTs by Le’Hereux and Saliba 
which included 31 case reports and short case 
series comprising 60 cases, the incidence of 
cranial nerve MNSTs were: VIII CN-60%; V 
CN-27%, VII CN-10%; III CN-6.7 %; IV CN-
1.7% &VI CN-1.7 %.[7] Etiologically, MPNST 
may occur infrequently when they arise de-
novo, occur in association with 
neurofibromatosis (NF) [5,7], may be 
consequent to radiation (conventional or SRS) 
or arise as malignant transformation of 
schwannoma or neurofibroma.[7] MPNSTs 
are highly malignant tumors that grow rapidly 
along nerves, infiltrate surrounding tissues 
and develop hematogenous metastasis. 
MPNSTs may develop hematogenous distant 
metastases (most commonly to Lungs; other 
sites being Bones and Liver.[5]   
MRI study does not allow confident 
distinction between benign and malignant 
nerve sheath tumors. A size more than 5 cm, 
infiltrative margins and marked signal 
heterogeneity, adjacent structure compression 
and local invasion are features which favor 
MPNSTs. The diagnosis of MPNSTs 
necessitates biopsy and remains controversial 
due to its lack of specific morphological 
criteria and immunohistochemical or 
molecular tests.[6] 
 Treatment of MPST is primarily surgical. 
Gross total excision of intracranial MPNSTs 
significantly influences overall survival rates 
and relates inversely with local recurrence. 
Complete surgical tumor resection with 
preservation of neurological function should 
be the goal of the treatment. However, critical 
location and stubborn nature of tumor, 
complete surgical resection can be challenging 
and is not always feasible.[1,7] The role of 
adjuvant Radiotherapy remains 
controversial.[7]  Numerous chemotherapy 
regimens have been used against MPNSTs but 
results have been unconvincing even when 
combined with surgery and radiotherapy.[3,7]  
In early stages of MNST Surgical resection of 
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the tumor provides survival benefits.  Whereas 
radiotherapy is useful in improving survival in 
metastatic MPNST. Combined therapy with 
surgery and radiotherapy are prognostically 
important in patient with tumors >5 cm. [2]   
Conclusion 
Intra-cranial olfactory MPNST is 
extremely rare. This is the probably first such 
reported case. Complete excision should be the 
goal of surgery which is the mainstay of 
treatment. However, due to the stubborn 
nature of tumor and intimate relation with 
critical neurovascular structures, this may not 
always be feasible. Combined therapy surgery 
with post op radiotherapy has some survival 
benefits in metastatic MPNST.
 
 
Figure 1 - Pre Op  contrast enhance MRI brain (axial, sagittal and coronal view) Showing anterior cranial fossa SOL 
 
 
Figure 2 - Post op NCCT Head axial and (sagittal view) showing complete excision of the tumor 
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